Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
South Africa reports successful third-line HIV treatment programme

People with resistance to first- and second-line antiretroviral drugs can still achieve high rates of viral suppression in the first year on third-line regimens according to a

Published
04 January 2019
By
Esther Nakkazi
HIV treatment outcomes continue to get better, says large analysis

The efficacy of first-line antiretroviral therapy (ART) continues to improve, according to an analysis of outcomes in 78,000 people in 181 studies, published in AIDS by Professor

Published
27 December 2018
By
Michael Carter
What's New in the U.S. HIV Clinical Guidelines

We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of HIV.

Published
21 December 2018
From
TheBody.com
Benefits of dolutegravir treatment for all substantially outweigh the risks

Providing an antiretroviral regimen of dolutegravir, tenofovir and lamivudine to all adults living with HIV in sub-Saharan Africa, regardless of viral suppression or plans to have children,

Published
17 December 2018
By
Keith Alcorn
How HIV Physicians Can Better Treat an Aging Population

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Published
12 December 2018
From
Poz
New BHIVA guidelines on HIV care in pregnancy and after birth

New British HIV Association (BHIVA) guidelines on the management of HIV in pregnancy have been issued this month, emphasising the continuing scientific uncertainty over HIV transmission through

Published
05 December 2018
By
Keith Alcorn
Brazil highlights treatment for all people with HIV

Ahead of World AIDS Day 2018, the Government of Brazil has announced the largest drop in AIDS-related deaths in the country, as a result of Brazil’s policy for greater access to HIV prevention, testing, treatment and care.

Published
01 December 2018
From
World Health Organization
All people with HIV-2 should receive HIV treatment – without it, most will progress to AIDS and death

Most people with HIV-2 infection will progress to AIDS and death unless they receive antiretroviral therapy (ART), according to the results of a study conducted in Guinea-Bissau and

Published
27 November 2018
By
Michael Carter
Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir

Dolutegravir-based treatment was no more effective than treatment based on a 400mg dose of efavirenz, a randomised trial conducted in Cameroon has found. However, almost half

Published
01 November 2018
By
Keith Alcorn
Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds

A study measuring HIV drug resistance at two timepoints in Kenyan patients on second-line, protease inhibitor-based regimens has found very high levels of drug resistance in people with

Published
22 October 2018
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.